We spoke to Dr. Marisa Spann about her work in early childhood psychiatry, her new role in the Office of Equity, Diversity and Inclusion, and having honest, direct conversations about race.
Adrian Jacques Ambrose, MD, MPH, FAPA, medical director of the Columbia Psychiatry Faculty Practice Organization, discusses the newest research into the neuroscience of anxiety and depression.
Dr. Jeffrey Lieberman and co-authors hypothesized that combining the xanomeline with trospium could lessen xanomeline's typical side effects in treating schizophrenia.
The Horga Lab is a psychiatry research lab that uses neuroimaging and cognitive methods to study the origins of the psychotic symptoms of schizophrenia, including hallucinations and delusions.
Researchers at Columbia University used magnetic resonance imaging (MRI) to understand brain structural alterations in children and adolescents with OCD that predict psychotherapy treatment response.
Neurogenesis is “fundamentally important for the brain to react to all sorts of different insults and prevent neurological and psychiatric problems,” Dr. Maura Boldrini says.
Dr. Rachel Marsh’s Cognitive Development and Neuroimaging Laboratory studies the mechanisms in the brain that underlie an individual’s ability to self-regulate.
While there is still plenty of research to be done, Dr. Philip Muskin emphasized that there is enough certainty to know that psychiatric drugs do work – often to great effect.